Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraneware Regulatory News (CRW)

Share Price Information for Craneware (CRW)

Share Price is delayed by 15 minutes
Get Live Data
1,440.00    8.00 (0.56%)
Bid:
1,434.00
Ask:
1,444.00
Spread: 10.00 (0.697%)
Market Cap: £493.01m
CRW Live PriceLast checked at - London Stock Exchange

Intraday Craneware Share Chart

Dividend Timetable

21 Sep 2021 17:58

RNS Number : 5194M
Craneware plc
21 September 2021
 

 

Craneware plc

("Craneware" or the "Company" or the "Group")

 

Dividend Timetable

 

 

21 September 2021 - Craneware (AIM: CRW.L), the market leader in Value Cycle software solutions for the US healthcare market, announces an amendment to the dividend timetable announced in its Final Results on 21 September 2021.

 

The revised dividend timetable is as follows:

 

 

Ex-dividend date

25 November 2021

Record date

26 November 2021

Dividend payment date

21 December 2021

 

The final dividend of 15.5p per share is capable of being paid in US dollars subject to a shareholder having registered to receive their dividend in US dollars under the Company's Dividend Currency Election, or who register to do so by the close of business on 26 November 2021. The exact amount to be paid will be calculated by reference to the exchange rate to be announced on 26 November 2021. The final dividend referred to within the Final Results announcement in US dollars of 21.47 cents is given as an example only using the Balance Sheet date exchange rate of $1.3853/£1 and may differ from that finally announced

 

 

For further information, please contact:

 

Craneware plc

+44 (0)131 550 3100

Keith Neilson, CEO

Craig Preston, CFO

Alma (Financial PR)

+44 (0)20 3405 0205

Caroline Forde, Hilary Buchanan, Robyn Fisher, Joe Pederzolli

craneware@almapr.co.uk

Peel Hunt (NOMAD and Joint Broker) 

+44 (0)20 7418 8900

Dan Webster, George Sellar, Andrew Clark

Investec Bank PLC (Joint Broker)

+44 (0)20 7597 5970

Patrick Robb, Henry Reast, Sebastian Lawrence

  

 

Berenberg (Joint Broker)

+44 (0)20 3207 7800

Mark Whitmore, Jack Botros, Alix Mecklenburg-Solodkoff

 

 

About Craneware

Craneware (AIM: CRW.L), the leader in automated value cycle solutions, collaborates with U.S. healthcare providers to plan, execute and monitor financial and operational performance so they can continue to drive better outcomes for the communities they serve. Craneware's Trisus platform combines revenue integrity, cost management and decision enablement into a single SaaS-based platform. Our flagship solution, Chargemaster Toolkit®, continually earns KLAS recognition in the Revenue Cycle - Chargemaster Management category and is part of our value cycle management suite, which includes charge capture, strategic pricing, 340B compliance, claims analytics, patient engagement, revenue recovery and retention, and cost and margin intelligence solutions.

 

Learn more at craneware.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVUAVNRANUKUAR
Date   Source Headline
2nd Oct 20144:25 pmRNSTotal Voting Rights
23rd Sep 201412:30 pmRNSHolding(s) in Company
23rd Sep 201412:25 pmRNSGrant of Options
16th Sep 20147:00 amRNSFinal Results
1st Sep 20145:20 pmRNSIssue of Consideration Shares
28th Aug 20147:00 amRNSBoard Appointment and Acquisition
17th Jul 201410:46 amRNSTransaction in Own Securities, Total Voting Rights
15th Jul 20147:00 amRNSTrading Update
28th Apr 20147:00 amRNSSignificant Contract Win
16th Apr 20145:00 pmRNSBlocklisting Interim Review
11th Apr 201412:05 pmRNSDirector/PDMR Shareholding
4th Apr 20144:27 pmRNSDirector/PDMR Shareholding
2nd Apr 20147:00 amRNSSignificant Contract Wins
31st Mar 20142:29 pmRNSDividend Currency Election
11th Mar 20147:00 amRNSHalf Yearly Report
16th Jan 20147:00 amRNSTrading Update and Notice of Results
22nd Nov 20134:57 pmRNSHolding(s) in Company
15th Nov 20137:00 amRNSDividend Currency Election
12th Nov 20135:52 pmRNSResult of AGM
12th Nov 20137:00 amRNSAGM Statement and Appointment
18th Oct 20131:57 pmRNSPosting of Annual Report, Notice of AGM
30th Sep 20132:20 pmRNSHolding(s) in Company
12th Sep 20136:25 pmRNSDirector/PDMR Shareholding
11th Sep 20134:40 pmRNSDirector/PDMR Shareholding
11th Sep 20138:50 amRNSGrant of Options
10th Sep 20137:00 amRNSFinal Results
12th Jul 20137:00 amRNSNotice of Results
26th Jun 20137:00 amRNSTrading Update
15th Apr 201311:09 amRNSBlocklisting Interim Review
12th Apr 20135:32 pmRNSTotal Voting Rights
18th Mar 20133:30 pmRNSDividend Currency Election
4th Mar 20134:29 pmRNSTotal Voting Rights
27th Feb 201312:29 pmRNSDirector/PDMR Shareholding
26th Feb 20137:00 amRNSHalf Yearly Report
15th Feb 201312:00 pmRNSHolding(s) in Company
21st Jan 20137:00 amRNSTrading Update
30th Nov 201212:41 pmRNSHolding(s) in Company
9th Nov 20127:00 amRNSDividend Currency Election
8th Nov 201211:45 amRNSResult of AGM
8th Nov 20128:00 amRNSAGM Statement
19th Oct 201212:54 pmRNSBlocklisting Interim Review
10th Oct 20125:32 pmRNSPosting of Annual Report & Notice of AGM
24th Sep 20125:22 pmRNSGrant of Options
19th Sep 20125:53 pmRNSHolding(s) in Company
17th Sep 201211:38 amRNSDirector/PDMR Shareholding
6th Sep 201211:35 amRNSDirector/PDMR Shareholding
4th Sep 20127:00 amRNSFinal Results
29th Aug 20127:00 amRNSesMD Certification
15th Aug 20127:00 amRNSNotice of Results
2nd Aug 20122:58 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.